OrthoAxis - Product

Product Overview

The AOS Magellan Femoral Nail is targeted for use in intramedullary fixation of fractures of the femur. Its unique screw configuration provides both versatility and diversity for the Antegrade/ Retrograde Nail designs. Its innovative features offer superior solutions for the orthopedic advancement of hip fractures.

FEATURES & BENEFITS

Antegrade Nail:
Versatile Screw Configurations
• Up to 3 proximal Screws in the proximal femur to form a K-like screw formation for increased stability. This consists of a one reconstruction, one antegrade and one transverse screw.
• 2 proximal screws may be inserted up the femoral head for a reconstruction configuration.
• Threaded holes to prevent screw back out.
• 8mm of Intra-operative or dynamic compression through the jig.
• Oblong Slot may be converted to a static transverse hole with the use of the AOS Spacer.

Anatomical in Design
• Anatomically accurate femoral bow.
• Antegrade screw targets the strong cortical bone of the lesser trochanter.
• Distal Screw Options.
• 3 Distal screw options.
• 8mm of dynamic compression.
• Distal screw options designed to be close to the tip of the nail.

Retrograde Nail:
Diverse Distal Screw Options for all fracture patterns
• Total of 4 distal screw options may be locked to the nail.
• Threaded holes for 3 points of fixation of the cortical bone.
• Oblique screws that target into the femoral condyles for condylar fractures.
• 7mm of Intra-operative or dynamic compression.

Easy to use Compression nut and washer system
• The carbon fiber targeter assists in accurate and precise insertion of the screw, nut and washer.

Targeted Supracondylar Nail
• Targeted & threaded distal holes.
• Anatomically accurate femoral bow.
• Reduced surgical and radiation time. (https://www.aosortho.com/)

Surgical Technique: Antegrade

Surgical Technique: Retrograde

Product Brochure

Advanced Orthopaedic Solutions Website

Technique Tips

Reviews

X-Rays

Visitors Also Viewed

Magellan Femoral Nail System

(0 Reviews)
(0 Comments)